vimarsana.com
Home
Live Updates
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript : vimarsana.com
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
GILD earnings call for the period ending March 31, 2024.
Related Keywords
Tennessee
,
United States
,
Japan
,
Maryland
,
Johanna Mercier
,
Salveen Richter Goldman Sachs
,
Merdad Parsey
,
Chris Schott Jpmorgan
,
Brian Abrahams
,
Carter Gould Barclays
,
Jacquie Ross
,
Cindy Perettie
,
Salveen Richter
,
Tyler Van Buren
,
Simon Baker Redburn Atlantic
,
Redburn Atlantic
,
Daina Graybosch Leerink
,
America Merrill Lynch
,
Terence Flynn Morgan Stanley
,
Randy Dickinson
,
Andrew Dickinson
,
Morgan Stanley
,
Michael Yee Jefferies
,
Chris Schott
,
James Shin Deutsche Bank Analyst
,
Goldman Sachs
,
Geoff Meacham Bank
,
Nvidia
,
Gilead Sciences
,
Department Of Corrections
,
Geoff Meacham At Bank
,
Company Analyst
,
James Shin At Deutsche Bank
,
Danielo Day
,
Motley Fool Stock Advisor
,
Stock Advisorservice
,
Stock Advisor
,
Chief Executive
,
Change Healthcare
,
Cell Therapy
,
Tennessee Oncology
,
Liver Disease
,
Daina Graybosch
,
Vice President
,
Umer Raffat
,
Geoff Meacham
,
Michael Yee
,
Maybei Ll
,
James Shin
,
Mohit Bansal
,
Fargo Securities
,
Trodelvy Phase
,
Simon Baker
,
Brian Skorney
,
Terence Flynn
,
Carter Gould
,
Leerink Partners
,
Executive Vice President
,
Deutsche Bank
,
Wells Fargo Securities
,
Chief Medical Officer
,
Chief Executive Officer
,
Hiv Prevention
,
Chief Commercial Officer
,
vimarsana.com © 2020. All Rights Reserved.